UNASSIGNED: As a result of increasing life expectancy, the @entity5 incidence in older population is on the rise. @entity43 ( @entity43 ) is predominantly the disease of elderly @entity1 . More than half of all @entity43 occur in @entity1 older than 65years. The incidence of the disease increases with the advancing age, peaking during 7th decade of life and remains elevated until the age of 80 years. With the changing demographic scenario the percentage of elderly @entity1 is increasing and gynaecologic oncologists need to focus more on these @entity1 and their specific needs. Due to their higher risk of morbidity and mortality compared to younger @entity1 , elderly @entity1 with advanced @entity43 are challenging to treat and are often treated less radically. Their outcome is impaired despite no consistent prognostic effect of age itself. To offer optimal radical management of the elderly @entity1 with @entity43 and to avoid suboptimal treatment, biological age and functional status need to be considered before individualized treatment plans are defined. Pretreatment assessment can be achieved by using different assessment tools. @entity1 can tolerate surgery and chemotherapy, as long as they are individually assessed for their medical, psychological, and functional capabilities before therapeutic intervention is initiated. Prospective trials involving elderly @entity1 with @entity43 are the need of the day to offer justified evidenced based optimal treatment for those who will be benefited from the treatment.

Management of XXXX in Elderly.

@entity5 :: ('MESH:D009369', 'Disease') :: ['cancer'] @entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients'] @entity43 :: ('MESH:D010051', 'Disease') :: ['OC', 'ovarian cancer', 'Ovarian cancer']
@entity43 :: (MESH:D010051,Disease) :: ['Ovarian Cancer']
